/

Empresas

Fo

No verificado

Forlong Biotechnology

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaOncologíaSalud

4 Comunicados de prensa

Ver todos los comunicados de prensa

30/10/2025

Oncología

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Eventos

Industria

Forlong Biotechology to Present Clinical Data from FL115, a novel interleukin-15 (IL-15) superagonist, in Late-breaking Session at 40th SITC Annual Meeting

Fuente

Forlong Biotechnology

Editor

1.00

0

30/10/2025

Eventos

Industria

Oncología

Salud

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Forlong Dosed First Patient in Phase 2 Clinical Trial of FL115, a novel interleukin-15 (IL-15) superagonist, for nonmuscle invasive bladder cancer (NMIBC)

Fuente

Forlong Biotechnology

Editor

1.00

0

22/10/2025

Oncología

Salud

Ciencia

Farmacéutica

Biotecnología

Mercado laboral

Forlong Biotechology Announces Collaboration Agreement with Henlius to Develop Innovative Cancer Immunotherapy with an Engineered Cytokine

Fuente

Forlong Biotechnology

Editor

1.00

0

14/10/2025

Biotecnología

Salud

Farmacéutica

Medicina - Varios

Oncología

Mercado laboral

Industria

Forlong Biotechnology Receives Milestone Payment as Partner Submits IND for A Protein Therapy using its Proprietary Fbody® Technology

Fuente

Forlong Biotechnology

Editor

1.00

0

Seguidores

0

Compatibilidad

0